Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity

被引:10
|
作者
Diwan, A. Hafeez [1 ]
Skelton, Henry G., III [2 ]
Horenstein, Marcelo G. [3 ]
Kelly, David R. [4 ]
Barrett, Terry L. [5 ]
Bussian, Anne H. [7 ]
Sanders, Deborah Y. [6 ]
Lazar, Alexander J. F. [1 ]
Prieto, Victor G. [1 ]
Smith, Kathleen J. [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Quest Diagnost, Tucker, GA USA
[3] Univ S Alabama, Dept Pathol, Mobile, AL 36688 USA
[4] Childrens Hosp, Dept Pathol, Birmingham, AL USA
[5] Propath, Dallas, TX USA
[6] Serv Dermatopathol, Birmingham, AL USA
[7] Skin Pathol Associates, Birmingham, AL USA
关键词
D O I
10.1111/j.1600-0560.2007.00872.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
According to most authors, dermatofibrosarcoma protuberans (DFSP) and giant cell fibroblastoma (GCF) represent the adult and juvenile forms, respectively, of the same disease entity, as evidenced by similar morphology, an identical chromosomal translocation, and CD34 positivity. It has been shown that DFSP and nuchal-type fibroma (NTF) (which is also CD34-positive) are related lesions, and that there might possibly be a continuum between the two. In addition, NTF exhibits CD99 positivity. It was therefore, hypothesized that both DFSP and GCF would show similar immunopositivity for CD99. Archives of pathology at several institutions were searched for DFSP and GCF tissue blocks. A total of 29 DFSP and 5 GCF were analyzed by immunohistochemistry for expression of CD99. Twenty-three of 29 DFSP (79%) and 2 of 5 GCP (40%) expressed CD99. Comparison of CD99 and CD34 showed that the non-tumoral periphery of DFSP was less probable to be CD99 positive, but this finding was not statistically significant.
引用
收藏
页码:647 / 650
页数:4
相关论文
共 50 条
  • [41] Genomic gains of COL1A1-PDGFB occur in the evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans:: A study of 13 cases with morphologic correlations
    Macarenco, R. S.
    Erickson-Johnson, M. R.
    Wang, X.
    Zamolyi, R.
    Nascimento, A. G.
    Oliveira, A. M.
    LABORATORY INVESTIGATION, 2007, 87 : 96A - 96A
  • [42] Use of a novel FISH assay as an adjunct to diagnosis of dermatofibrosarcoma priatuberans and giant cell fibroblastoma
    Peck, H. R.
    Nelson, M.
    Pedentour, F.
    Gatalica, Z.
    Miettinen, M.
    Bridge, J. A.
    LABORATORY INVESTIGATION, 2008, 88 : 368A - 369A
  • [43] Dermatofibrosarcoma promberans and giant cell fibroblastoma: Two clinical and histologic variants of the same cytogenetic disease?
    Wain, E. Mary
    Robson, Alistair
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB84 - AB84
  • [44] Targeting CD99 in T-cell neoplasms
    Tavakkoli, Montreh
    Lee, Dong H.
    Chung, Stephen S.
    Park, Christopher Y.
    CANCER RESEARCH, 2015, 75
  • [45] Cell Adhesion Molecule CD99 in Cancer Immunotherapy
    Yu, Feng
    Liu, Guodong
    Zhang, Hailing
    Wang, Xiaoyan
    Wu, Zhi
    Xu, Qinggang
    Wu, Yan
    Chen, Dongfeng
    CURRENT MOLECULAR MEDICINE, 2023, 23 (10) : 1028 - 1036
  • [46] Childhood pilomatrixoma mimicking malignant small round blue cell tumor with positivity for CD99: Potential pitfall in cytology
    Singh, Brijdeep
    Srinivasan, Radhika
    Bansal, Deepak
    Rohilla, Manish
    Dey, Pranab
    Saikia, Uma Nahar
    Nada, Ritambhra
    DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (11) : E301 - E307
  • [47] CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
    Manara, Maria Cristina
    Pasello, Michela
    Scotlandi, Katia
    GENES, 2018, 9 (03):
  • [48] CD99 isoforms dictate T cell functional outcomes
    Alberti, I
    Bernard, G
    Jazdanian, AKR
    Pelassy, C
    Monique, P
    Aussel, C
    Bernard, A
    FASEB JOURNAL, 2003, 17 (07): : C4 - C5
  • [49] CD99 plays an important role in glioblastoma cell migration
    Cardoso, Lais C.
    Lerario, Antonio M.
    Marie, Suely K.
    Soares, Roseli S.
    Oba-Shinjo, Sueli M.
    CANCER RESEARCH, 2017, 77
  • [50] Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: Clinicopathologic comparative analysis of 28 cases with molecular data - A study from the French Federation of cancer centers sarcoma group
    Terrier-Lacombe, MJ
    Guillou, L
    Maire, G
    Terrier, P
    Vince, DR
    Somerhausen, NDS
    Collin, F
    Pedeutour, F
    Coindre, JM
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (01) : 27 - 39